Norman Fields Gottscho Capital Management’s Elanco Animal Health ELAN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q4
Sell
-22,915
Closed -$284K 72
2022
Q3
$284K Sell
22,915
-4,565
-17% -$79.8K 0.14% 58
2022
Q2
$539K Sell
27,480
-290
-1% -$6.86K 0.25% 50
2022
Q1
$725K Sell
27,770
-1,700
-6% -$45.3K 0.27% 50
2021
Q4
$836K Buy
29,470
+3,825
+15% +$119K 0.31% 49
2021
Q3
$818K Hold
25,645
0.32% 43
2021
Q2
$890K Sell
25,645
-77,900
-75% -$2.57M 0.36% 41
2021
Q1
$3.05M Buy
103,545
+965
+0.9% +$29.7K 1.33% 21
2020
Q4
$3.15M Buy
102,580
+60,555
+144% +$1.85M 1.4% 21
2020
Q3
$1.17M Buy
+42,025
New +$1.07M 0.58% 29

Other funds holding ELAN

Norman Fields Gottscho Capital Management's ELAN Position: Q4 2022 in Review

Norman Fields Gottscho Capital Management sold out of Elanco Animal Health (ELAN) in Q4 2022, closing a stake of 22,915 shares — an estimated $284K sold.

Norman Fields Gottscho Capital Management first reported a position in ELAN in Q3 2020 and held it in 9 quarters. The position peaked at $3.15M in Q4 2020. 404 funds tracked by Wall St. Rank hold ELAN as of Q4 2022.

  • Norman Fields Gottscho Capital Management reported no remaining Elanco Animal Health position as of Q4 2022 after selling out during the quarter.
  • Norman Fields Gottscho Capital Management sold 22,915 Elanco Animal Health shares in Q4 2022, an estimated $284K.
  • Norman Fields Gottscho Capital Management first reported a position in Elanco Animal Health in Q3 2020 and held it in 9 quarters.
  • Norman Fields Gottscho Capital Management's Elanco Animal Health position peaked at $3.15M in Q4 2020.
  • 404 funds tracked by Wall St. Rank held Elanco Animal Health as of Q4 2022.

Based on Norman Fields Gottscho Capital Management's 13F filing for Q4 2022, filed 4 Jan 2023.